Phibro Animal Health Corporation announced the appointment of Joyce J. Lee, MBA, as a Class II independent director to its Board of Directors, effective immediately. This appointment fills a current vacancy, increasing the Board's membership to nine directors, with six now being independent.
Ms. Lee brings extensive experience from her previous role as President of Cobb Vantress LLC, a genetics company. She also held executive positions at Elanco, Bayer Animal Health, and Zoetis, demonstrating a broad background in the animal health industry.
Her career includes leadership roles in global genetics production, general management, strategy, sales, marketing, outcomes research, R&D, engineering, manufacturing, and information technology. Her strategic vision and industry knowledge are expected to be valuable assets to Phibro's governance and strategic direction.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.